Improving clinical trial efficiency by biomarker-guided patient selection

被引:0
|
作者
Ruud Boessen
Hiddo J Lambers Heerspink
Dick De Zeeuw
Diederick E Grobbee
Rolf HH Groenwold
Kit CB Roes
机构
[1] University Medical Center Utrecht,Julius Center for Health Sciences and Primary Care
[2] University Medical Center Groningen,Department of Clinical Pharmacology
来源
Trials | / 15卷
关键词
Clinical trial designs; Biomarkers; Baseline selection; Active run-in;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Improving clinical trial efficiency by biomarker-guided patient selection
    Boessen, Ruud
    Heerspink, Hiddo J. Lambers
    De Zeeuw, Dick
    Grobbee, Diederick E.
    Groenwold, Rolf H. H.
    Roes, Kit C. B.
    TRIALS, 2014, 15
  • [2] Biomarker-guided clinical trial designs: sample size calculations with survival endpoints
    Antoniou, Miranta
    Kolamunnage-Dona, Ruwanthi
    Jorgensen, Andrea L.
    TRIALS, 2017, 18
  • [3] Reducing the risk of failure: biomarker-guided trial design
    Michael J. Townsend
    Joseph R. Arron
    Nature Reviews Drug Discovery, 2016, 15 : 517 - 518
  • [4] Evaluating statistical characteristics of biomarker-guided trial designs
    Miranta Antoniou
    Andrea Jorgensen
    Ruwanthi Kolamunnage-Dona
    Trials, 16
  • [5] Reducing the risk of failure: biomarker-guided trial design
    Townsend, Michael J.
    Arron, Joseph R.
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (08) : 517 - 518
  • [6] Evaluating statistical characteristics of biomarker-guided trial designs
    Antoniou, Miranta
    Jorgensen, Andrea
    Kolamunnage-Dona, Ruwanthi
    TRIALS, 2015, 16
  • [7] Biomarker-Guided Tailored Therapy
    Lydiard, Jessica
    Nemeroff, Charles B.
    FRONTIERS IN PSYCHIATRY: ARTIFCIAL INTELLIGENCE, PRECISION MEDICINE, AND OTHER PARADIGM SHIFTS, 2019, 1192 : 199 - 224
  • [8] Biological and analytical variation of clinical biomarker testing: Implications for biomarker-guided therapy
    Wu A.H.B.
    Current Heart Failure Reports, 2013, 10 (4) : 434 - 440
  • [9] Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial
    Scriba, Thomas J.
    Fiore-Gartland, Andrew
    Penn-Nicholson, Adam
    Mulenga, Humphrey
    Mbandi, Stanley Kimbung
    Borate, Bhavesh
    Mendelsohn, Simon C.
    Hadley, Katie
    Hikuam, Chris
    Kaskar, Masooda
    Musvosvi, Munyaradzi
    Bilek, Nicole
    Self, Steven
    Sumner, Tom
    White, Richard G.
    Erasmus, Mzwandile
    Jaxa, Lungisa
    Raphela, Rodney
    Innes, Craig
    Brumskine, William
    Hiemstra, Andriette
    Malherbe, Stephanus T.
    Hassan-Moosa, Razia
    Tameris, Michele
    Walzl, Gerhard
    Naidoo, Kogieleum
    Churchyard, Gavin
    Hatherill, Mark
    LANCET INFECTIOUS DISEASES, 2021, 21 (03): : 354 - 365
  • [10] Phase II cancer clinical trials for biomarker-guided treatments
    Jung, Sin-Ho
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2018, 28 (02) : 256 - 263